A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s

被引：17

作者：

Subasinghe, NL ^{[1
]}

Travins, JM ^{[1
]}

Ali, F ^{[1
]}

Huang, H ^{[1
]}

Ballentine, SK ^{[1
]}

Marugán, JJ ^{[1
]}

Khalil, E ^{[1
]}

Hufnagel, HR ^{[1
]}

Bone, RF ^{[1
]}

DesJarlais, RL ^{[1
]}

Crysler, CS ^{[1
]}

Ninan, N ^{[1
]}

Cummings, MD ^{[1
]}

Molloy, CJ ^{[1
]}

Tomczuk, BE ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Exton, PA 19341 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 08期

关键词：

classical pathway; complement; C1s; complement inhibitor; C1s inhibitor; classical pathway inhibitor;

D O I：

10.1016/j.bmcl.2006.01.036

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibiting the classical pathway of complement activation by attenuating the proteolytic activity of the serine protease C1s is a potential strategy for the therapeutic intervention in disease states such as hereditary angioedema, ischemia-reperfusion injury, and acute transplant rejection. A series of arylsulfonylthiophene-2-carboximidine inhibitors of C1s were synthesized and evaluated for C1s inhibitory activity. The most potent compound had a K-i of 10 nM and >1000-fold selectivity over uPA, tPA, FXa, thrombin, and plasmin. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：2200 / 2204

页数：5

共 50 条

[1] Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s
Travins, Jeremy M.
Ali, Farah
Huang, Hui
Ballentine, Shelley K.
Khalil, Ehab
Hufnagel, Heather R.
Pan, Wenxi
Gushue, Joan
Leonard, Kristi
Bone, Roger F.
Soll, Richard M.
DesJarlais, Renee L.
Crysler, Carl S.
Ninan, Nisha
Kirkpatrick, Jennifer
Cummings, Maxwell D.
Huebert, Norman
Molloy, Christopher J.
Gaul, Michael
Tomczuk, Bruce E.
Subasinghe, Nalin L.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) : 1603 - 1606
[2] A novel series of potent and selective small molecule inhibitors of the complement component C1s
Subasinghe, NL
Ali, A
Illig, CR
Rudolph, MJ
Klein, S
Khalil, E
Soll, RM
Bone, RF
Spurlino, JC
DesJarlais, RL
Crysler, CS
Cummings, MD
Morris, PE
Kilpatrick, JM
Babu, YS
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (12) : 3043 - 3047
[3] Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s
Subasinghe, Nalin L.
Khalil, Ehab
Travins, Jeremy M.
Ali, Farah
Ballentine, Shelley K.
Hufnagel, Heather R.
Pan, Wenxi
Leonard, Kristi
Bone, Roger F.
Soll, Richard M.
Crysler, Carl S.
Ninan, Nisha
Kirkpatrick, Jennifer
Huebert, Norman
Molloy, Christopher J.
Tomczuk, Bruce E.
Gaul, Michael D.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[4] Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s
Subasinghe, Nalin L.
Khalil, Ehab
Travins, Jeremy M.
Ali, Farah
Ballentine, Shelley K.
Hufnagel, Heather R.
Pan, Wenxi
Leonard, Kristi
Bone, Roger F.
Soll, Richard M.
Crysler, Carl S.
Ninan, Nisha
Kirkpatrick, Jennifer
Kolpak, Michael X.
Diloreto, Karen A.
Eisennagel, Stephen H.
Huebert, Norman D.
Molloy, Christopher J.
Tomczuk, Bruce E.
Gaul, Michael D.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (16) : 5303 - 5307
[5] FRAGMENTATION OF FOURTH COMPONENT OF HUMAN COMPLEMENT BY C1S
PATRICK, RA
LEPOW, IH
[J]. FEDERATION PROCEEDINGS, 1969, 28 (02) : 817 - &
[6] Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway
Ikeda, Zenichi
Kamei, Taku
Sasaki, Yusuke
Reynolds, Matthew
Sakai, Nozomu
Yoshikawa, Masato
Tawada, Michiko
Morishita, Nao
Dougan, Douglas R.
Chen, Chien-Hung
Levin, Irena
Zou, Hua
Kuno, Masako
Arimura, Naoto
Kikukawa, Yusuke
Kondo, Mitsuyo
Tohyama, Kimio
Sato, Kenjiro
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (09) : 6354 - 6371
[7] ISOLATION OF 2 FORMS OF ACTIVATED C1S, A SUBCOMPONENT OF 1ST COMPONENT OF RABBIT COMPLEMENT
ISHIZAKI, E
YOSHIOKA, Y
MORI, Y
KOYAMA, J
[J]. JOURNAL OF BIOCHEMISTRY, 1976, 80 (06): : 1423 - 1427
[8] 1ST COMPLEMENT COMPONENT - EVIDENCE FOR AN EQUILIBRIUM BETWEEN C1S FREE IN SERUM AND C1S BOUND IN C1-COMPLEX
BARTHOLOMEW, RM
ESSER, AF
[J]. JOURNAL OF IMMUNOLOGY, 1977, 119 (06): : 1916 - 1922
[9] C1 INHIBITOR - DIFFERENT MECHANISMS OF REACTION WITH COMPLEMENT COMPONENT C1 AND C1S
HORTIN, GL
TRIMPE, BL
[J]. IMMUNOLOGICAL INVESTIGATIONS, 1991, 20 (01) : 75 - 82
[10] ISOLATION AND CHARACTERIZATION OF PROENZYME FORM OF C1S SUBUNIT OF FIRST COMPLEMENT COMPONENT
VALET, G
COOPER, NR
[J]. JOURNAL OF IMMUNOLOGY, 1974, 112 (01): : 339 - 350

← 1 2 3 4 5 →